CJ

Charmiben Jayeshbhai Patel

Active Director Director DIN 09272020
DIN 09272020 First appointment Aug 2021 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Charmiben Jayeshbhai Patel

Data last updated:

Charmiben Jayeshbhai Patel is a Director at Shine Pathology Services Private Limited (since 2021). The company operates in Non-Profit Organizations.

DIN 09272020
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 06 Aug 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Aug 20212021Active

Board colleagues of Charmiben Jayeshbhai Patel

Directorship timeline

Open interactive timeline →
Shine Pathology Services Private Limited
Premium access

Shareholding and investment profile for Charmiben Jayeshbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Charmiben Jayeshbhai Patel

Charmiben Jayeshbhai Patel currently holds 1 directorship: Shine Pathology Services Private Limited (Director, since 06 Aug 2021).

Charmiben Jayeshbhai Patel was first appointed on 06 Aug 2021 as Director at Shine Pathology Services Private Limited.

The current boards of Charmiben Jayeshbhai Patel's companies include Bivekanand Kushwaha (Shine Pathology Services Private Limited), Nimeshkumar Christian (Shine Pathology Services Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available